首页> 外文期刊>The Journal of Thoracic and Cardiovascular Surgery >Elective femoro-femoral cardiopulmonary bypass during transcatheter aortic valve implantation: A useful tool
【24h】

Elective femoro-femoral cardiopulmonary bypass during transcatheter aortic valve implantation: A useful tool

机译:经导管主动脉瓣植入术中的选择性股-股-体外循环:一种有用的工具

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Objective: Transcatheter aortic valve implantation is a new method to treat high-risk patients with aortic valve stenosis. The operative risk can be reduced, especially in patients with severely reduced left ventricular function or cardiogenic shock. Nevertheless, this new procedure has some potential risks, especially during the phases of rapid pacing (valvuloplasty and valve deployment). The use of cardiopulmonary bypass allows the perioperative risk to be reduced. Method: Between April 2008 and August 2011, 512 consecutive patients underwent transcatheter aortic valve implantation. Cardiopulmonary bypass was used in 35 patients. In this special group, there were 17 men and 18 women with a mean age of 77 ?? 12 years (range, 38-92 years). Left ventricular ejection fraction was a mean of 32% ?? 19% (range, 10%-70%), European System for Cardiac Operative Risk Evaluation was 60% ?? 27% (range, 13%-97%), and Society of Thoracic Surgeons' mortality score was 35% ?? 28% (range, 4%-90%). Results: Cardiopulmonary bypass was used in 13 patients with preoperative cardiogenic shock, 11 patients with impaired heart function during the procedure, 7 patients with severely impaired left ventricular function (left ventricular ejection fraction, 17% ?? 6%; range, 10%-30%), 3 patients with concomitant conventional surgical procedures, and 1 patient with impaired right ventricular function. The technical success rate was 94%, 30-day mortality was 20%, and 1-year survival was 46%. Conclusions: The use of cardiopulmonary bypass enhances safety in critical transcatheter aortic valve implantation procedures. Furthermore, transcatheter aortic valve implantation with cardiopulmonary bypass seems to provide better results than medical therapy or conventional aortic valve replacement in critically ill patients. The need for cardiopulmonary bypass emphasizes that the procedure should be performed only in cooperation between cardiologists and cardiac surgeons.
机译:目的:经导管主动脉瓣植入术是治疗高危主动脉瓣狭窄患者的一种新方法。可以降低手术风险,特别是在左室功能严重下降或心源性休克的患者中。然而,这种新方法存在一些潜在的风险,尤其是在快速起搏阶段(瓣膜成形术和瓣膜展开)。使用体外循环可以降低围手术期的风险。方法:自2008年4月至2011年8月,连续512例患者接受了经导管主动脉瓣植入术。 35例患者使用了体外循环。在这个特殊群体中,平均年龄为77 ??的男性有17位,女性有18位。 12年(范围38-92岁)。左心室射血分数平均为32% 19%(范围10%-70%),欧洲心脏手术风险评估系统为60%? 27%(范围13%-97%),并且胸外科医师学会的死亡率得分是35%。 28%(范围4%-90%)。结果:13例术前心源性休克患者,11例心功能受损的患者,7例左心功能严重受损的患者(左心室射血分数为17%≤6%;范围为10%- 30%),3例同时进行常规外科手术和1例右心功能受损的患者。技术成功率为94%,30天死亡率为20%,一年生存率为46%。结论:体外循环的使用增强了关键性经导管主动脉瓣植入手术的安全性。此外,在危重患者中,经心肺旁路经导管主动脉瓣植入似乎比药物治疗或常规主动脉瓣置换提供更好的结果。体外循环的需要强调,该程序仅应在心脏病专家和心脏外科医师之间合作进行。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号